FOUR GENERATIONS COMMITTED TO OVERCOMING INFECTIOUS DISEASES
Marcel Mérieux
1897
Marcel Mérieux, a student of Louis Pasteur, creates the Institut Biologique Mérieux.
Dr. Charles Mérieux
1937
Dr. Charles Mérieux succeeds his father Marcel. He launches production of the foot-and-mouth disease vaccine. This marks the birth of industrial virology.
IFFA
1947
Dr. Charles Mérieux creates IFFA (Institut Français de Fièvre Aphteuse).
BD Mérieux
1963
Alain Mérieux creates BD Mérieux, an in vitro diagnostics company jointly owned by Institut Mérieux and Becton Dickinson.
Fondation Mérieux
1967
Dr. Charles Mérieux creates Fondation Mérieux.
Alain Mérieux
1967
Alain Mérieux succeeds his father as the head of Institut Mérieux, which will become a world leader in the field of human and veterinary vaccines.
Rhône-Poulenc
1968
Groupe Rhône-Poulenc acquires a stake in Institut Mérieux.
bioMérieux
1974
Alain Mérieux takes over BD Mérieux which becomes bioMérieux.
Institut Pasteur Production
1985
Institut Mérieux acquires Institut Pasteur Production (vaccines).
API Systems
1987
bioMérieux acquires API Systems (bacterial identification).
Vitek
1988
bioMérieux acquires Vitek Systems (bacterial identification and susceptibility testing automation) from McDonnell Douglas, a North American company.
Connaught Laboratories
1989
Institut Mérieux acquires Connaught Laboratories (vaccines)
Divestment of vaccine business
1994
The Mérieux family divests from its vaccine business (Rhône-Poulenc buys Institut Mérieux, which includes Pasteur Mérieux Sérums et Vaccins and Rhône Mérieux, now Sanofi Pasteur and Merial).
Transgene
1994
The Mérieux family takes control of Transgene (immunotherapy).
Stock market listing
1998
Transgene is listed on the stock exchange.
Silliker
1998
The Mérieux family holding company takes control of Silliker Group Corporation (food safety).
Organon Teknika
2001
bioMérieux acquires Organon Teknika (diagnostics).
Fondation Rodolphe Mérieux
2001
Creation of Fondation Rodolphe Mérieux (which will become Fondation Christophe et Rodolphe Mérieux in 2006).
Stock market listing
2004
bioMérieux is listed on the stock market (Euronext Paris).
Personalized medicine
2005
Launch of the ADNA program on personalized medicine supported by the French government.
Institut Mérieux
2009
The Mérieux Alliance holding company changes its name to Institut Mérieux to revive the historic name.
Mérieux Développement
2009
Creation of Mérieux Développement (Investment company).
Mérieux Research Grants
2009
Launch of the international innovation program Mérieux Research Grants.
Mérieux NutriSciences
2010
Development of the nutrition/health unit Mérieux NutriSciences.
BioFire
2014
bioMérieux acquires BioFire (syndromic diagnostics).
Alexandre Mérieux
2015
Alexandre Mérieux becomes CEO of bioMérieux.